Unique clinical and biological features of leukemia in Down syndrome children

Peripheral blood cell counts in infants with Down's syndrome

(2010) S. M. Kivivuori et al.   CLINICAL GENETICS

ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells

(2009) M. J. Stankiewicz et al.   BLOOD

Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome

(2009) D. C. Cabelof et al.   BLOOD

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

(2009) L. Hertzberg et al.   BLOOD

Breastfeeding and early infection in the aetiology of childhood leukaemia in Down syndrome

(2009) J Flores-Lujano et al.   BRITISH JOURNAL OF CANCER

ERG Is a Megakaryocytic Oncogene

(2009) S. Salek-Ardakani et al.   CANCER RESEARCH

Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant

(2009) Ritsuko Shimizu et al.   GENES TO CELLS

Down Syndrome and Malignancies: A Unique Clinical Relationship

(2009) Ana C. Xavier et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia

(2009) Charles G Mullighan et al.   NATURE GENETICS

Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: A Children's Oncology Group study

(2009) Simona Ognjanovic et al.   PEDIATRIC BLOOD & CANCER

Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia

(2008) Rosa M. Ayala et al.   AMERICAN JOURNAL OF HEMATOLOGY

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations

(2008) O. Tunstall-Pedoe et al.   BLOOD

Trisomy 21 enhances human fetal erythro-megakaryocytic development

(2008) S. T. Chou et al.   BLOOD

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

(2008) J.-H. Klusmann et al.   BLOOD

Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia

(2008) L. Kearney et al.   BLOOD

Congenital Abnormalities and Acute Leukemia among Children with Down Syndrome: A Children's Oncology Group Study

(2008) A. M. Linabery et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Acute leukemia in children with Down's syndrome: the importance of population based study

(2008) R. James et al.   HAEMATOLOGICA

Cardiomyopathy in Children With Down Syndrome Treated for Acute Myeloid Leukemia: A Report From the Children's Oncology Group Study POG 9421

(2008) Maureen M. O'Brien et al.   JOURNAL OF CLINICAL ONCOLOGY

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

(2008) Dani Bercovich et al.   LANCET

Acute lymphoblastic leukaemia

(2008) Ching-Hon Pui et al.   LANCET